Table 5.

Prevalence of albuminuria and left ventricular hypertrophy according to HbA1c among all patients and patients with controlled hypertension

	HbA1c
	≥7.0%	6.5%‐6.9%	<6.5%
All patients
Albuminuria
Number of patients(n = 428)	62/200	14/84	25/144
Prevalence of albuminuria (%)	31.0%	16.7%	17.4%
Odds ratio (95% CI)*	‐	0.46 (0.24‐0.89)	0.48 (0.28‐0.84)
P value	‐	.02	.01
Left ventricular hypertrophy
Number of patients (n = 766)	19/376	2/134	10/256
Prevalence of left ventricular hypertrophy (%)	5.1%	1.5%	3.9%
Odds ratio (95% CI)*	‐	0.34 (0.08‐1.51)	0.82(0.36‐1.87)
P value	‐	.15	.63
Patients with controlled hypertension
Albuminuria
Number of patients(n = 221)	17/92	5/41	13/88
Prevalence of albuminuria (%)	18.5%	12.2%	14.8%
Odds ratio (95% CI)*	‐	0.55 (0.18‐1.67)	0.72 (0.31‐1.64)
P value	‐	.29	.43
Left ventricular hypertrophy
Number of patients (n = 388)	8/171	5/69	6/148
Prevalence of left ventricular hypertrophy (%)	4.7%	7.3%	4.1%
Odds ratio (95% CI)*	‐	0.53 (0.06‐4.78)	0.53(0.13‐2.26)
P value	‐	.57	.39

Abbreviation: CI, confidence interval.

^*Adjusted for age, sex, body mass index, current smoking and alcohol intake, serum total cholesterol and triglycerides, and heart rate.